Human Microbiome Market - Top Companies and Manufacturers

  • Report ID: 4062
  • Published Date: Oct 10, 2024
  • Report Format: PDF, PPT

Companies Dominating the Human Microbiome Landscape

    • Seres Therapeutics, Inc.
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Evelo Biosciences, Inc.
    • Synlogic, Inc.
    • Second Genome Inc.
    • Synthetic Biologics, Inc.
    • YSOPIA Bioscience
    • 4D Pharma plc
    • DuPont de Nemours, Inc.
    • BiomX Inc.
    • Sun Genomics, Inc.
    • Viome Life Sciences, Inc.

Browse Key Market Insights with Data Illustration:

In the News

  • Viome Life Sciences, Inc. launched the CancerDetect test for oral and throat cancer. Further, this test also fills a market gap by offering advanced, early detection at the point when it is most controllable and is the first to find biomarkers for early-stage oral and throat cancers.
  • Seres Therapeutics, Inc. teamed up with Bacthera to produce SER-109, for reoccurring Clostridium difficile infection (rCDI). Further, the collaboration enhanced the initial commercial manufacturing supply chain, which will strengthen SER-109's commercial production capacities and provide supply support.

 

 


Author Credits:  Radhika Pawar


  • Report ID: 4062
  • Published Date: Oct 10, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of human microbiome is estimated at USD 561.5 million.

The human microbiome market size was over USD 445.92 million in 2024 and is projected to cross USD 11.73 billion by the end of 2037, witnessing more than 32.2% CAGR during the forecast period i.e., between 2025-2037. Growing prevalence of the human microbiome in health and disease and increasing research on its major impact on human physiology, metabolic and immune functions will boost the market growth.

North America is poised to account for the largest share of 35% by 2037, driven by rising pet adoption in the region.

The major players in the market include Seres Therapeutics, Inc., Evelo Biosciences, Inc., Synlogic, Inc., Second Genome Inc., Synthetic Biologics, Inc., YSOPIA Bioscience, 4D Pharma plc, DuPont de Nemours, Inc., BiomX Inc., Sun Genomics, Inc., Viome Life Sciences, Inc.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample